Vaughan Nelson Investment Management L.P. Acquires 458,620 Shares of Bath & Body Works, Inc. $BBWI

Vaughan Nelson Investment Management L.P. boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 27.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,132,245 shares of the company’s stock after buying an additional 458,620 shares during the quarter. Vaughan Nelson Investment Management L.P. owned approximately 1.04% of Bath & Body Works worth $42,815,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of BBWI. First Horizon Corp bought a new position in shares of Bath & Body Works in the third quarter worth about $29,000. Geneos Wealth Management Inc. grew its holdings in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Danske Bank A S bought a new stake in shares of Bath & Body Works during the 3rd quarter valued at approximately $39,000. Advisory Services Network LLC acquired a new position in Bath & Body Works during the 3rd quarter worth approximately $48,000. Finally, Carolina Wealth Advisors LLC bought a new position in Bath & Body Works in the 3rd quarter valued at approximately $54,000. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock opened at $18.73 on Tuesday. The firm has a market cap of $3.77 billion, a price-to-earnings ratio of 5.95, a PEG ratio of 1.68 and a beta of 1.48. Bath & Body Works, Inc. has a one year low of $14.27 and a one year high of $34.66. The stock’s 50-day moving average is $21.56 and its 200 day moving average is $22.24.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.77 by $0.28. The company had revenue of $2.72 billion for the quarter, compared to the consensus estimate of $2.59 billion. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. Bath & Body Works’s quarterly revenue was down 2.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.09 EPS. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 6th. Stockholders of record on Friday, February 20th were paid a $0.20 dividend. The ex-dividend date was Friday, February 20th. This represents a $0.80 annualized dividend and a dividend yield of 4.3%. Bath & Body Works’s dividend payout ratio (DPR) is currently 25.40%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on BBWI shares. Citigroup lowered shares of Bath & Body Works from a “buy” rating to a “neutral” rating and raised their target price for the company from $21.00 to $25.00 in a research report on Tuesday, February 17th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, January 21st. Guggenheim started coverage on Bath & Body Works in a report on Tuesday, December 9th. They set a “neutral” rating on the stock. Barclays boosted their price target on Bath & Body Works from $20.00 to $21.00 and gave the stock an “equal weight” rating in a report on Monday, March 2nd. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a report on Tuesday, March 3rd. Three analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $24.00.

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.